52-week range
Price risk
Balance sheet & cash
Was the rally earned?
Partly.
- Most of the rise came from investors paying a higher multiple (P/E 49.4x to 92.5x); per-share earnings added 22 points.
- The share count rose 3%.
What do "pts" mean?
"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.
Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.
Not shown for 3 years and 5 years: earnings were negative at one end, or there is not enough history.
Net profit is trailing twelve months as reported with a 60-day lag.
What is the price implying?
At a P/E of 140.3x, the price would imply about 40.1%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.
Fewer than six years of annual earnings are available, which is too little to measure delivered growth.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Producer Manufacturing The market-wide Expectations lists
What changed?
- Oct '26Fell 30% from the Sep 2026 peak to the Oct 2026 low.
- Jul '26Volume reached 24.2x its 50-day median on 2026-07-01; price +10.0% that day.
- Jun '26Year-on-year EPS growth turned positive.
- Jun '26Regained the 2025-01 peak, 3 months after the low.
- Jun '26Moved into the 2nd quartile of Producer Manufacturing on EPS growth (from the 3rd quartile).
- Jun '26Volume reached 33.3x its 50-day median on 2026-06-25; price -4.6% that day.
- Mar '26Fell 47% from the Jan 2025 peak to the Mar 2026 low.
- Mar '26Volume reached 11.2x its 50-day median on 2026-03-30; price -4.0% that day.
Show 9 earlier events
- Jan '26Debt / equity halved over 12 months to 0.10x.
- Jan '26Share count is up 200.0% over 12 months.
- Dec '25Slipped to the 2nd quartile of Producer Manufacturing on operating margin (from the top quartile).
- Nov '25Slipped to the 3rd quartile of Producer Manufacturing on ROCE (from the 2nd quartile).
- Sep '25Moved into the top quartile of Producer Manufacturing on operating margin (from the 2nd quartile).
- Sep '25Volume reached 7.4x its 50-day median on 2025-09-16; price +3.8% that day.
- Jun '25Slipped to the 2nd quartile of Producer Manufacturing on operating margin (from the top quartile).
- May '25Volume reached 5.5x its 50-day median on 2025-05-29; price +7.5% that day.
- Feb '25Slipped to the 2nd quartile of Producer Manufacturing on ROCE (from the top quartile).
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Are profits backed by cash?
3 of 5 checks are within range, 2 beyond a threshold.
Tap a check to see how it is measured.
Other income reliance14%Within range
Other income as a share of pre-tax profit (trailing twelve months): 14.3%. Bands: below 15%, 15% to 35%, above 35%.
Tax rate26%Within range
Median quarterly effective tax rate over about 2.5 years: 26.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.
Cash conversion-0.07xBeyond threshold
Operating cash flow divided by net profit over the last three fiscal years: -0.07x (cash from operations ₹-15 cr, net profit ₹212 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.
Free cash flow0 of 5 yrsBeyond threshold
Fiscal years with positive free cash flow in the last 5: 0. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history—Not enough data
Not enough reported data to compute this.
Capital work in progress15% of fixed assetsWithin range
Capital work-in-progress is 15% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days—Not enough data
Not enough reported data to compute this.
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
Who has been buying and selling?
- Since Mar 2025, DIIs trimmed 2.0 pts.
- The number of shareholders fell from 67,159 to 47,340 (-30%) between Mar 2025 and Jun 2026.
Holdings, Jun '26
How each group changed
Number of shareholders
Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.
How rough has the ride been?
Monthly share price
Last 90 trading days
Drawdown from peak
Largest drawdowns
-47.0% (2025-01 peak to 2026-03 low, recovered 2026-06)
-30.2% (2026-09 peak to 2026-10 low, not yet recovered)
Most recent volume spikes
2026-07-07: 6x the 50-day median, price -2.5% that day
2026-07-06: 7.5x the 50-day median, price -5.0% that day
2026-07-03: 8.7x the 50-day median, price -5.0% that day
Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).
Where does it rank among Producer Manufacturing peers?
Each cell is the company's percentile rank among its Producer Manufacturing peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Producer Manufacturing sector page Watch it move against Producer Manufacturing in the Observatory
What else looks like this?
Companies with the most similar financial profile today, regardless of industry.
| Company | Sector | Similarity | Closest on |
|---|---|---|---|
| FINEOTEX CHEMICAL (FCL) | Process Industries | 61% | operating margin, promoter holding |
| YATHARTH HOSPITAL TRAUMA (YATHARTH) | Health Services | 60% | market cap, debt/equity |
| PARAS DEFENCE AND SPACE TECH (PARAS) | Electronic Technology | 58% | P/E, market cap |
| ARTEMIS MEDICARE SERVICES (ARTEMISMED) | Health Services | 54% | ROCE, promoter holding |
| RESPONSIVE INDUSTRIES (RESPONIND) | Non-Energy Minerals | 51% | promoter holding, debt/equity |
| MARINE ELECTRICALS INDIA (MARINE) | Producer Manufacturing | 64% | P/E, revenue |
| KRN HEAT EXCHANGER n REFR (KRN) | Producer Manufacturing | 62% | market cap, revenue |
| AEROFLEX INDUSTRIES (AEROFLEX) | Producer Manufacturing | 55% | P/E, market cap |
Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.
What happened next to similar setups
- We found 50 past situations where a non-financial company looked like STANDARD ENGINEERING TECHNOLOG today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
- Over the following 12 months the middle half of them returned −37% to +20% vs the market, against −4% for all non-financial companies in the same months.
- The gap against the base rate (+1.1%, 80% range −17.1% to +11.0%) is within what chance and overlapping periods produce.
Where the 50 outcomes landed
Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 1 beyond the range shown, drawn at the edge
50 past situations · 50 companies · 33 months · 2020–2025
The closest matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| ACUTAAS Process Industries |
Feb 2025 | 91x | 16% | +95% | −17% | +69% |
| KAYNES Electronic Technology |
Jan 2024 | 173x | 22% | +266% | −2% | +56% |
| RATEGAIN Technology Services |
Dec 2023 | 115x | 10% | +155% | −2% | −15% |
| BECTORFOOD Consumer Non-Durables |
Oct 2023 | 73x | 21% | +194% | −5% | +21% |
| LAURUSLABS Health Technology |
Jan 2021 | 72x | 14% | +301% | −9% | +7% |
Show the other 3 matches
How reliable is this?
Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: size, drawdown from 12-month high and P/S. One match per company and at most 7 from any one month.
Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.
Monthly history (22 months)
| Month | P/E | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|---|
| 2026-10 | 92.5x | ₹850 cr | 10.8% | 15.0% | 0.1x |
| 2026-09 | 98.8x | ₹850 cr | 10.8% | 15.0% | 0.1x |
| 2026-08 | 92.1x | ₹775 cr | 10.1% | 15.0% | 0.1x |
| 2026-07 | 68.6x | ₹775 cr | 10.1% | 15.0% | 0.1x |
| 2026-06 | 64.0x | ₹775 cr | 10.1% | 15.0% | 0.1x |
| 2026-05 | 35.3x | ₹714 cr | 10.6% | 16.0% | 0.1x |
| 2026-04 | 37.0x | ₹714 cr | 10.6% | 16.0% | 0.1x |
| 2026-03 | 27.9x | ₹714 cr | 10.6% | 16.0% | 0.1x |
| 2026-02 | 34.4x | ₹662 cr | 10.0% | 16.0% | 0.1x |
| 2026-01 | 31.8x | ₹662 cr | 10.0% | 16.0% | 0.1x |
| 2025-12 | 41.4x | ₹662 cr | 10.0% | 16.0% | 0.1x |
| 2025-11 | 43.5x | ₹644 cr | 10.2% | 16.0% | 0.1x |
| 2025-10 | 49.4x | ₹644 cr | 10.2% | 16.0% | 0.1x |
| 2025-09 | 46.9x | ₹644 cr | 10.2% | 16.0% | 0.1x |
| 2025-08 | 51.8x | ₹613 cr | 9.3% | 16.0% | 0.1x |
| 2025-07 | 53.7x | ₹613 cr | 9.3% | 16.0% | 0.1x |
| 2025-06 | 49.0x | ₹613 cr | 9.3% | 16.0% | 0.1x |
| 2025-05 | 46.4x | ₹648 cr | 18.1% | 24.0% | 0.3x |
| 2025-04 | 34.9x | ₹648 cr | 18.1% | 24.0% | 0.3x |
| 2025-03 | 37.0x | ₹648 cr | 18.1% | 24.0% | 0.3x |
| 2025-02 | 34.0x | ₹646 cr | 17.2% | 24.0% | 0.3x |
| 2025-01 | 44.0x | ₹646 cr | 17.2% | 24.0% | 0.3x |